I'm A Patient
I'm A Provider
Dry AMD Affects more than 200 Million People Globally
There’s never been a proven solution to improve vision loss from dry AMD. Until MacuMira.
MacuMira is Canada’s first—and only—clinically proven treatment for dry age-related macular degeneration. MacuMira is a safe, painless, and noninvasive dry AMD treatment delivered in short appointments at your local eye clinic. Clinical results showed patients experienced improved visual clarity in just 10 days.
Learn how MacuMira can improve precious sight for people living with dry AMD.
Learn More About MacuMira for Dry AMD
MacuMira: A Completely Unique Approach to Dry AMD
Dry age-related macular degeneration (AMD) can cast a shadow over daily life, because it affects not only your vision, but also your independence and peace of mind. For some, the gradual loss of sight disrupts everyday routines. For others, an early diagnosis of dry AMD brings the worry of developing a highly heritable eye disease seen in loved ones.
Until now, dry AMD management has focused on prevention. But MacuMira changes that. As the first and only Health Canada-cleared device designed to improve visual function for those affected by dry AMD, MacuMira provides a groundbreaking, noninvasive approach to clearer vision.
Your sight and your quality of life matter. MacuMira is here to support you every step of the way.
How MacuMira Works
Microcurrent Stimulation
MacuMira uses Microcurrent Stimulation to support retinal health. It’s the first and only treatment of its kind for dry AMD, built on technology that has been safely used for decades.
Improved Vision
A clinical trial showed 100% of patients saw improved visual function after 6 treatments over 30 weeks. On average, patients had improved visual acuity (ETDRS assessment of number of letters read) and contrast sensitivity within 4 weeks of the first treatment. With continued treatment, vision may be able to be maintained indefinitely.
Painless In-Office Therapy
MacuMira requires no injections, medication, lasers, or surgery. Patients simply visit their eye care provider on a prescribed schedule, relax while wearing the MacuMira device for about half an hour, and get on with their day.
Find a MacuMira Provider Near You for Vision-Restoring Dry AMD Treatment
Optometrists across Canada can provide MacuMira therapy to improve patients’ quality of life with dry AMD. If you or a loved one live with dry AMD, find a participating eye clinic near you or contact us for help.
Download the Clinical Trial
The MacuMira clinical trial, published in the International Journal of Retina and Vitreous, found the following:
100%
of patients in the treatment group showed improved vision
48%
of patients improved by at least 10 letters on the ETDRS acuity chart
8.2 ETDRS letters
Average improvement, along with a 25% average increase in ETDRS acuity
0
adverse effects of treatment
100%
of treated patients maintained their vision improvements for the duration of the trial
Articles
Understanding how dry AMD affects you or your family member can make it a little easier to navigate. Learn more about this eye disease in our articles.
Your Guide to Dry Age-related Macular Degeneration: Key Treatments and Care Strategies
BlogDry age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, leading to gradual central vision loss. As the most common form of AMD, it typically develops slowly. Early detection and management are crucial for maintaining eye health. Understanding In dry AMD, the macula thins over time, often accompanied by the formation of […]
Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
BlogAge-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It comes in two forms: dry (atrophic) and wet (neovascular). While dry AMD progresses gradually over time, wet AMD can cause sudden and severe vision loss. A common question among patients and caregivers is whether wet macular degeneration can turn […]
Read More… from Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
What is geographic atrophy (GA)?
BlogHow it’s related to dry AMD and who’s the most at risk For those with dry age-related macular degeneration (dry AMD), there’s always a risk that this condition could develop into geographic atrophy (GA), a condition where retinal pigment epithelial (RPE) cells start to die off. Research estimates that there are approximately 180,000 new cases of GA […]
Your Guide to Dry Age-related Macular Degeneration: Key Treatments and Care Strategies
Dry age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, leading to gradual central vision loss. As the most common form of AMD, it typically develops slowly. Early detection and management are crucial for maintaining eye health. Understanding In dry AMD, the macula thins over time, often accompanied by the formation of […]
Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It comes in two forms: dry (atrophic) and wet (neovascular). While dry AMD progresses gradually over time, wet AMD can cause sudden and severe vision loss. A common question among patients and caregivers is whether wet macular degeneration can turn […]
Read More… from Can Wet Macular Degeneration Turn Into Dry Macular Degeneration?
What is geographic atrophy (GA)?
How it’s related to dry AMD and who’s the most at risk For those with dry age-related macular degeneration (dry AMD), there’s always a risk that this condition could develop into geographic atrophy (GA), a condition where retinal pigment epithelial (RPE) cells start to die off. Research estimates that there are approximately 180,000 new cases of GA […]
Corporate:
#302, 815 – 1st Street SW
Calgary, AB
T2P 1N3
info@macumira.com
1-844-619-6263
Mailing Address:
MacuMira Medical Devices Inc
#136 1811 4th Street SW
Calgary, AB
T2S 1W2
Hours:
Mon-Fri: 8am – 5pm
Sat – Sun: Closed